Salter A M, Saxton J, Brindley D N
Biochem J. 1986 Dec 1;240(2):549-57. doi: 10.1042/bj2400549.
The binding of human low-density lipoprotein labelled with 125I to rat hepatocytes in monolayer culture was measured at 4 degrees C. Evidence for two different specific binding sites was obtained. Binding to Site 1 was characterized by: being displaced by dextran sulphate or heparin; being dependent on Ca2+; having a Kd value of about 15 micrograms of protein/ml; not being significantly displaced by a 20-fold excess unlabelled low-density lipoprotein that had been reductively methylated; being displaced by approx. 40% by a 20-fold protein excess of unlabelled human high-density lipoprotein, HDL3, and increasing with time in culture when newborn-calf serum was present in the medium. The binding to Site 2 had the following properties: it was not displaced by sulphated polysaccharides; it was only partially Ca2+-dependent, and the presence of EDTA increased the Kd value; the apparent Kd value in the presence of Ca2+ was approx. 30 micrograms of protein/ml, which was significantly higher than for Site 1; it was displaced by approx. 30% with a 20-fold excess of low-density lipoprotein that had been methylated; it was displaced by unlabelled HDL3 to a similar extent to Site 1; it did not increase significantly with time in culture. The characteristics of binding to Sites 1 and 2 are discussed in relation to the receptors for low-density lipoproteins that have previously been described in various cell types. It is proposed that the experimental system described in this paper is suitable for studying the regulation of the binding of low-density lipoproteins to hepatocytes.
在4℃下测定了用125I标记的人低密度脂蛋白与单层培养的大鼠肝细胞的结合。获得了存在两种不同特异性结合位点的证据。与位点1的结合具有以下特征:可被硫酸葡聚糖或肝素取代;依赖于Ca2+;Kd值约为15微克蛋白质/毫升;不会被20倍过量的经还原甲基化的未标记低密度脂蛋白显著取代;可被20倍蛋白质过量的未标记人高密度脂蛋白HDL3取代约40%,并且当培养基中存在新生牛血清时,结合随培养时间增加。与位点2的结合具有以下特性:不会被硫酸化多糖取代;仅部分依赖于Ca2+,并且EDTA的存在会增加Kd值;在存在Ca2+的情况下,表观Kd值约为30微克蛋白质/毫升,显著高于位点1;可被20倍过量的甲基化低密度脂蛋白取代约30%;被未标记的HDL3取代的程度与位点1相似;不会随培养时间显著增加。结合位点1和2的结合特性与先前在各种细胞类型中描述的低密度脂蛋白受体相关进行了讨论。本文提出所描述的实验系统适用于研究低密度脂蛋白与肝细胞结合的调节。